Genetic analysis of the most common type of bladder cancer yields guidance on treatment options

byUNC Lineberger Comprehensive Cancer CenterUC-GENOME study design and molecular subtyping shows enrichment of Stroma-rich primary tumors in metastatic datasets. Credit:Nature Communicatio

Updated on: December 21,2023 10

Genetic analysis of the most common type of bladder cancer yields guidance on treatment options

byUNC Lineberger Comprehensive Cancer CenterUC-GENOME study design and molecular subtyping shows enrichment of Stroma-rich primary tumors in metastatic datasets. Credit:Nature Communicatio

Updated on:December 21,2023 10

Investigating quality of life in those with large B-cell lymphoma

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainPatient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that tho

Updated on: December 20,2023 10

Investigating quality of life in those with large B-cell lymphoma

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainPatient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that tho

Updated on:December 20,2023 10

AI's Breakthroughs in Ovarian Cancer Diagnosis and Treatment

Updated on: June 12,2024 0

AI's Breakthroughs in Ovarian Cancer Diagnosis and Treatment

Updated on:June 12,2024 0

New fast, effective way to detect cancer stem cells

New fast, effective way to detect cancer stem cellsby Fram Dinshaw,McMaster UniversityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101108McMaster

Updated on: October 28,2023 8

New fast, effective way to detect cancer stem cells

New fast, effective way to detect cancer stem cellsby Fram Dinshaw,McMaster UniversityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101108McMaster

Updated on:October 28,2023 8

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph

Updated on: October 21,2024 0

Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph

Updated on:October 21,2024 0

Scientists reveal a potential new approach to treating liver cancer

byNational Institutes of Healtha, Schematic of drug screening and validation studies; MoA, mechanism of action.b, Graphs of the results from the small-molecule screen with the MIPE library

Updated on: December 27,2023 9

Scientists reveal a potential new approach to treating liver cancer

byNational Institutes of Healtha, Schematic of drug screening and validation studies; MoA, mechanism of action.b, Graphs of the results from the small-molecule screen with the MIPE library

Updated on:December 27,2023 9

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),

Updated on: December 25,2023 15

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),

Updated on:December 25,2023 15

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n

Updated on: December 20,2023 10

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n

Updated on:December 20,2023 10

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit

Updated on: December 25,2023 11

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit

Updated on:December 25,2023 11

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed

Updated on: December 17,2023 10

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma—a biochemist explains how it works

by Mark R. O'Brian,The ConversationCredit: Pixabay/CC0 Public DomainMediaoutletshave reported the encouraging findings of clinical trials for a new experimental vaccine developed

Updated on:December 17,2023 10

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients

Updated on: October 24,2023 2

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients

Updated on:October 24,2023 2

Symptom self-monitoring for childhood cancer survivors—what are oncologists' views?

byKing's College LondonCredit: Unsplash/CC0 Public DomainA new international survey, led by the Stanford University Department of Anesthesiology, Perioperative, and Pain Medicine, and the In

Updated on: December 21,2023 10

Symptom self-monitoring for childhood cancer survivors—what are oncologists' views?

byKing's College LondonCredit: Unsplash/CC0 Public DomainA new international survey, led by the Stanford University Department of Anesthesiology, Perioperative, and Pain Medicine, and the In

Updated on:December 21,2023 10